Gilead Sciences, Inc.GILDNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 30.95% |
| Q3 2025 | -0.59% |
| Q2 2025 | 8.51% |
| Q1 2025 | -32.40% |
| Q4 2024 | 31.99% |
| Q3 2024 | 2.40% |
| Q2 2024 | 0.15% |
| Q1 2024 | -12.97% |
| Q4 2023 | 20.15% |
| Q3 2023 | -28.88% |
| Q2 2023 | 40.18% |
| Q1 2023 | -34.70% |
| Q4 2022 | 66.53% |
| Q3 2022 | -10.61% |
| Q2 2022 | 25.30% |
| Q1 2022 | -34.36% |
| Q4 2021 | 38.66% |
| Q3 2021 | -11.92% |
| Q2 2021 | 28.06% |
| Q1 2021 | -39.02% |
| Q4 2020 | 56.42% |
| Q3 2020 | -10.73% |
| Q2 2020 | 15.15% |
| Q1 2020 | -10.63% |
| Q4 2019 | 14.45% |
| Q3 2019 | -3.93% |
| Q2 2019 | 6.31% |
| Q1 2019 | -8.93% |
| Q4 2018 | 19.30% |
| Q3 2018 | -3.27% |
| Q2 2018 | -1.71% |
| Q1 2018 | -20.37% |
| Q4 2017 | 42.43% |
| Q3 2017 | -2.01% |
| Q2 2017 | 5.53% |
| Q1 2017 | -14.31% |
| Q4 2016 | 19.37% |
| Q3 2016 | -6.63% |
| Q2 2016 | 29.93% |
| Q1 2016 | -35.74% |